金斯瑞生物科技(01548)发布公告,2025年5月7日完成了与ProbioCayman的股份转让交易。根据公告,金斯瑞生物科技通过受让人持有3亿股Probio Cayman A类优先股,完成后金斯瑞生物科技直接及间接持有Probio Cayman约85.09%的权益,其中直接持有约6.64%,通过全资附属公司间接持有约65.08%,以及通过受让人持有约13.37%。此次股份转让的交割条件均已满足...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.